Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

9,878 total articles

Director Sells Shares Amid Mixed Analyst Signals for Trade Desk

Director Sells Shares Amid Mixed Analyst Signals for Trade Desk

Trade Desk director Samantha Jacobson sold a significant block of company stock totaling over $1.13 million. Despite the sale, which occurred while the underlying stock price had risen to $23.23 from its recent lows, recent corporate developments include Q1 results that slightly beat estimates and the appointment of a new CFO, though these positive…

Insider Activity and Financial Metrics at Bread Financial Holdings

Insider Activity and Financial Metrics at Bread Financial Holdings

Bread Financial’s leadership recently executed a significant sale of common stock. Despite this insider activity, the company reported an improvement in its net principal loss rate for April 2026 and noted growth in its loan portfolio. Additionally, Bread Financial is undergoing capital structure changes, including the issuance of new preferred sha…

TransUnion Executive Sells Shares Under Trading Plan Amid Strong Quarterly Results and Strategic Partnerships

TransUnion Executive Sells Shares Under Trading Plan Amid Strong Quarterly Results and Strategic Partnerships

The Chief Legal Officer at TransUnion recently sold a significant amount of company stock through a pre-arranged trading plan. This insider activity is reported alongside positive operational news, including the company's first quarter 2026 earnings that surpassed analyst expectations. Furthermore, TransUnion announced a quarterly dividend and expa…

Major Shareholder Sells Stock in Sensei Biotherapeutics Amid Clinical Progress and Analyst Optimism

Major Shareholder Sells Stock in Sensei Biotherapeutics Amid Clinical Progress and Analyst Optimism

A significant transaction was reported involving a major shareholder in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE). On June 1, 2026, James Peyer, who holds a ten percent ownership stake in the company, sold shares totaling $500,542. This sale occurred while the stock had seen substantial gains, rising nearly 19% over the preceding week and trading …

Newegg Director Sells Shares Following Volatile Trading Period

Newegg Director Sells Shares Following Volatile Trading Period

Fred Faching Chang, a director and significant shareholder of Newegg Commerce, Inc. (NASDAQ:NEGG), executed two notable sales of company common stock in late May. These reported insider transactions suggest activity from an internal stakeholder amid the stock's highly volatile trading history. The total value of the shares sold across these transac…